Asbury A. K. New concepts of Guillain-Barré syndrome. J Child Neurol. 2000 Mar;15(3):183-91.
Van den Berg B, Walgaard C, Drenthen J, et al. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014 Aug;10(8):469-82.
Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019 Nov;15(11):671-683.
Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013 May;31(2):491-510.
Hughes R. A., Hadden R., Gregson N., Smith K. Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol. 1999 Dec;100(1-2):74-97.
Hughes R. A. Campylobacter jejuni in Guillain-Barre syndrome. Lancet Neurol. 2004 Nov;3(11):644.
Yuki N. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Jpn J Infect Dis. 1999 Jun;52(3):99-105.
Yuki N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. J Infect Dis. 1997 Dec;176(2):S150-3.
Govoni V., Granieri E. Epidemiology of the Guillain-Barre syndrome. Curr Opin Neurol. 2001 Oct;14(5):605-13.
Yoshikawa H. Epidemiology of Guillain-Barré Syndrome. Brain Nerve. 2015 Nov;67(11):1305-11.
McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain- Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150-63.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain- Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123-33.
Супонева Н.А. Синдром Гийена-Барре: эпидемиология, дифференциальная диагностика, патоморфоз, факторы риска: дис. ... д-р.мед.наук: 14.01.11 нервные болезни, 14.03.03 - патологическая физиология / ФГБНУ НЦН, Москва, 2013, 305 с.
Hughes R. A. The concept and classification of Guillain-Barré syndrome and related disorders. Rev Neurol (Paris). 1995 May;151(5):291-4
Wakerley BR, Uncini A, Yuki N; GBS Classification Group; GBS Classification Group. Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014 Sep;10(9):537-44.
Van der Meché FG, Van Doorn PA, Meulstee J, Jennekens FG; GBS-consensus group of the Dutch Neuromuscular Research Support Centre. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol. 2001;45(3):133-9.
Hadden RD, Cornblath DR, Hughes RA, et al. Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998 Nov;44(5):780-8.
Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013 Dec;12(12):1180-8.
Sekiguchi Y, Mori M, Misawa S, et al. How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol. 2016 Jun;23(6):1058-63.
Ito M., Kuwabara S, Odaka M, et al. Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008 May;255(5):674-82.
Ito M., Matsuno K., Sakumoto Y., et al. Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):294-9. doi: 10.1136/jnnp.2010.222836. Epub 2011 Jan 20.
Uncini, A., Yuki, N. Sensory Guillain-Barré syndrome and related disorders: an attempt at systematization. Muscle Nerve. 2012 Apr;45(4):464-70.
Asbury, A. K.., Cornblath, D. R. Assessment of current diagnostic criteria for Guillain- Barré syndrome. Ann Neurol. 1990;27:21-4.
Willison, H. J., Jacobs, B. C., van Doorn, P. A. Guillain-Barré syndrome. Lancet. 2016 Aug 13;388(10045):717-27.
Walgaard C, Lingsma HF, Ruts L, et al. Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. 2010 Jun;67(6):781-7.
Wakerley, B. R., Yuki, N. Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes. Pract Neurol. 2015 Apr;15(2):90-9.
Uncini, A., Kuwabara, S. Electrodiagnostic criteria for Guillain-Barré syndrome: a critical revision and the need for an update. Clin. Neurophysiol. 2012;123:1487–1495.
Uncini, A., Kuwabara, S. The electrodiagnosis of Guillain-Barré syndrome subtypes: where do we stand? Clin Neurophysiol. 2018 Dec;129(12):2586-2593.
Cornblath D. R. Electrophysiology in Guillain-Barre syndrome. Ann Neurol. 1990;27:17- 20.
Rajabally Y. A., Durand M. C., Mitchel, J., et al. Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice? J. Neurol. Neurosurg. Psychiatry. 2015;86:115–119.
Van den Bergh PYK, Piéret F, Woodard JL, et al. Guillain-Barré syndrome subtype diagnosis: a prospective multicentric European study. Muscle Nerve. 2018;58:23-28.
Preston D.C., Shapiro B.E. Electromyography and neuromuscular disorders (Third Edition). Elsevier Health Sciences; 2012; pp. 664.
Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014 Jan;137(Pt 1):33-43.
Islam MB, Islam Z, Farzana KS, et al. Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria. J Peripher Nerv Syst. 2016 Dec;21(4):345-351.
Mateen FJ, Cornblath DR, Jafari H, et al. Guillain-Barré Syndrome in India: population- based validation of the Brighton criteria. Vaccine. 2011 Dec 6;29(52):9697-701.
Reza Boostani, Farveh Ramezanzadeh, Morteza Saeidi and Mina Khodabandeh. A follow- up study on Guillain-Barre syndrome and validation of Brighton criteria. Iran J Neurol. 2019 Apr 4; 18(2): 64–69.